Feng Dong
9Patents
4h-index
51Co-inventors
56Inventor score
Filing activity: Feb 6, 2009 → Jul 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8188234B2 | 1D05 PCSK9 antagonists | Chemistry; Metallurgy | 87 | Active |
| US8188233B2 | 1B20 PCSK9 antagonists | Chemistry; Metallurgy | 81 | Active |
| US8697070B2 | 1D05 PCSK9 antagonists | Chemistry; Metallurgy | 13 | Active |
| US9550986B2 | High-throughput antibody humanization | Physics | 4 | Active |
| US8877900B2 | AX132 PCSK9 antagonists | Chemistry; Metallurgy | 3 | Active |
| US8802827B2 | AX1 PCSK9 antagonists | Chemistry; Metallurgy | 3 | Active |
| US11639390B2 | Anti-alpha-4-beta-7 antibodies | Chemistry; Metallurgy | 2 | Active |
| US8957194B2 | 1B20 PCSK9 antagonists | Chemistry; Metallurgy | 2 | Active |
| US9840554B2 | Antibodies against platelet-derived growth factor (PDGF) | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.